Thrivent Financial for Lutherans’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-28,748
| Closed | -$190K | – | 2521 |
|
2025
Q1 | $190K | Hold |
28,748
| – | – | ﹤0.01% | 2324 |
|
2024
Q4 | $250K | Buy |
+28,748
| New | +$250K | ﹤0.01% | 2453 |
|
2023
Q4 | – | Sell |
-39,465
| Closed | -$359K | – | 2522 |
|
2023
Q3 | $359K | Sell |
39,465
-26,711
| -40% | -$243K | ﹤0.01% | 2249 |
|
2023
Q2 | $700K | Sell |
66,176
-10,848
| -14% | -$115K | ﹤0.01% | 2029 |
|
2023
Q1 | $942K | Hold |
77,024
| – | – | ﹤0.01% | 1822 |
|
2022
Q4 | $956K | Sell |
77,024
-64,201
| -45% | -$797K | ﹤0.01% | 1758 |
|
2022
Q3 | $1.93M | Buy |
141,225
+51,738
| +58% | +$707K | 0.01% | 1241 |
|
2022
Q2 | $1.64M | Buy |
+89,487
| New | +$1.64M | ﹤0.01% | 1370 |
|
2021
Q3 | – | Sell |
-14,300
| Closed | -$298K | – | 2498 |
|
2021
Q2 | $298K | Sell |
14,300
-30,827
| -68% | -$642K | ﹤0.01% | 2332 |
|
2021
Q1 | $1.28M | Sell |
45,127
-31,053
| -41% | -$877K | ﹤0.01% | 1724 |
|
2020
Q4 | $2.49M | Buy |
+76,180
| New | +$2.49M | 0.01% | 1180 |
|